ANIP FY 2013 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$30M+1207.5% YoY

Gross Profit

$20M66.8% margin

Operating Income

$898,0003.0% margin

Net Income

$301,0001.0% margin

EPS (Diluted)

$-0.92

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$6M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$45M

Total Liabilities

$4M

Stockholders' Equity

$41M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$2M	+1207.5%
Gross Profit	$20M	-$7M	+392.9%
Operating Income	$898,000	-$23M	+103.9%
Net Income	$301,000	-$28M	+101.1%